147 related articles for article (PubMed ID: 27653476)
1. Identification of HIV-1-Based Virus-like Particles by Multifrequency Atomic Force Microscopy.
González-Domínguez I; Gutiérrez-Granados S; Cervera L; Gòdia F; Domingo N
Biophys J; 2016 Sep; 111(6):1173-1179. PubMed ID: 27653476
[TBL] [Abstract][Full Text] [Related]
2. Characterization of HIV-1 virus-like particles and determination of Gag stoichiometry for different production platforms.
Lavado-García J; Jorge I; Boix-Besora A; Vázquez J; Gòdia F; Cervera L
Biotechnol Bioeng; 2021 Jul; 118(7):2660-2675. PubMed ID: 33844274
[TBL] [Abstract][Full Text] [Related]
3. Probing and pressing surfaces of hepatitis C virus-like particles.
Collett S; Torresi J; Earnest-Silveira L; Christiansen D; Elbourne A; Ramsland PA
J Colloid Interface Sci; 2019 Jun; 545():259-268. PubMed ID: 30897421
[TBL] [Abstract][Full Text] [Related]
4. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
[TBL] [Abstract][Full Text] [Related]
5. Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells.
Puente-Massaguer E; Lecina M; Gòdia F
Appl Microbiol Biotechnol; 2020 Feb; 104(4):1569-1582. PubMed ID: 31907573
[TBL] [Abstract][Full Text] [Related]
6. Polymer-grafted chromatography media for the purification of enveloped virus-like particles, exemplified with HIV-1 gag VLP.
Pereira Aguilar P; Schneider TA; Wetter V; Maresch D; Ling WL; Tover A; Steppert P; Jungbauer A
Vaccine; 2019 Nov; 37(47):7070-7080. PubMed ID: 31300289
[TBL] [Abstract][Full Text] [Related]
7. The retroviral capsid domain dictates virion size, morphology, and coassembly of gag into virus-like particles.
Ako-Adjei D; Johnson MC; Vogt VM
J Virol; 2005 Nov; 79(21):13463-72. PubMed ID: 16227267
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
9. Purification of HIV-1 gag virus-like particles and separation of other extracellular particles.
Steppert P; Burgstaller D; Klausberger M; Berger E; Aguilar PP; Schneider TA; Kramberger P; Tover A; Nöbauer K; Razzazi-Fazeli E; Jungbauer A
J Chromatogr A; 2016 Jul; 1455():93-101. PubMed ID: 27286649
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Particles of mRNA with Artificial Minimal Coat Proteins: Particle Formation, Stability, and Transfection Efficiency.
Jekhmane S; de Haas R; Paulino da Silva Filho O; van Asbeck AH; Favretto ME; Hernandez Garcia A; Brock R; de Vries R
Nucleic Acid Ther; 2017 Jun; 27(3):159-167. PubMed ID: 28437166
[TBL] [Abstract][Full Text] [Related]
11. RMCE-based insect cell platform to produce membrane proteins captured on HIV-1 Gag virus-like particles.
Vidigal J; Fernandes B; Dias MM; Patrone M; Roldão A; Carrondo MJT; Alves PM; Teixeira AP
Appl Microbiol Biotechnol; 2018 Jan; 102(2):655-666. PubMed ID: 29143881
[TBL] [Abstract][Full Text] [Related]
12. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
[TBL] [Abstract][Full Text] [Related]
13. Quality Assessment of Virus-Like Particles at Single Particle Level: A Comparative Study.
González-Domínguez I; Puente-Massaguer E; Cervera L; Gòdia F
Viruses; 2020 Feb; 12(2):. PubMed ID: 32079288
[TBL] [Abstract][Full Text] [Related]
14. Quantification of the HIV-1 virus-like particle production process by super-resolution imaging: From VLP budding to nanoparticle analysis.
González-Domínguez I; Puente-Massaguer E; Cervera L; Gòdia F
Biotechnol Bioeng; 2020 Jul; 117(7):1929-1945. PubMed ID: 32242921
[TBL] [Abstract][Full Text] [Related]
15. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
16. Detection of the Assembly and Disassembly of PCV2b Virus-Like Particles Using Fluorescence Spectroscopy Analysis.
Fang M; Diao W; Dong B; Wei H; Liu J; Hua L; Zhang M; Guo S; Xiao Y; Yu Y; Wang L; Wan M
Intervirology; 2015; 58(5):318-23. PubMed ID: 26783743
[TBL] [Abstract][Full Text] [Related]
17. High-throughput process development of an alternative platform for the production of virus-like particles in Escherichia coli.
Ladd Effio C; Baumann P; Weigel C; Vormittag P; Middelberg A; Hubbuch J
J Biotechnol; 2016 Feb; 219():7-19. PubMed ID: 26707548
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence fluctuation spectroscopy on viral-like particles reveals variable gag stoichiometry.
Chen Y; Wu B; Musier-Forsyth K; Mansky LM; Mueller JD
Biophys J; 2009 Mar; 96(5):1961-9. PubMed ID: 19254556
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
20. Differential N- and O-glycosylation signatures of HIV-1 Gag virus-like particles and coproduced extracellular vesicles.
Lavado-García J; Zhang T; Cervera L; Gòdia F; Wuhrer M
Biotechnol Bioeng; 2022 May; 119(5):1207-1221. PubMed ID: 35112714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
